Literature DB >> 16780461

'Cure' of life-threatening antiphospholipid syndrome with rituximab.

A Anandacoomarasamy, J Gibson, N McGill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16780461     DOI： 10.1111/j.1445-5994.2006.01113.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN： 1444-0903            Impact factor:   2.048


× No keyword cloud information.
  4 in total

Review 1.  Use of rituximab in the antiphospholipid syndrome.

Authors:  Deepak Kumar; Robert A S Roubey
Journal:  Curr Rheumatol Rep       Date:  2010-02       Impact factor: 4.592

2.  Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment.

Authors:  Jinhai Wang; Jay Lozier; Gibbes Johnson; Susan Kirshner; Daniela Verthelyi; Anne Pariser; Elizabeth Shores; Amy Rosenberg
Journal:  Nat Biotechnol       Date:  2008-08       Impact factor: 54.908

Review 3.  The potential utility of B cell-directed biologic therapy in autoimmune diseases.

Authors:  D G Arkfeld
Journal:  Rheumatol Int       Date:  2007-10-24       Impact factor: 2.631

4.  Efficacy and Safety of Rituximab in Systemic Lupus Erythematosus and Sjögren Syndrome Patients With Refractory Thrombocytopenia: A Retrospective Study of 21 Cases.

Authors:  Bin Jiang; Ting Li; Li Guo; Hao Shen; Shuang Ye; Sheng Chen
Journal:  J Clin Rheumatol       Date:  2015-08       Impact factor: 3.517
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.